Ledger.Open graph →

SEC Form D · filed April 21, 2022

Aurion Biotech, Inc

Offering

$11K

Sold

$11K

Exemption

Rule 506(c)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (27)

Jeannette Bankes · SEATTLE, WADirector Arnaud Lacoste · SEATTLE, WAExec Link William · SEATTLE, WADirector David Rostov · SEATTLE, WAExec Christine Mccauley · SEATTLE, WADirector Andrew Elbardissi · SEATTLE, WADirector Patrick Lally · SEATTLE, WADirector Tom Frinzi · SEATTLE, WADirector Greg Kunst · SEATTLE, WAExec · Director Switzer Robert · Long Beach, CADirector White Robert · Long Beach, CADirector Rich Johnson · Long Beach, CAExec Elvin Lopez · Whippany, NJDirector Jennifer Stapp · Long Beach, CAExec Jennifer Frist · NASHVILLE, TNDirector Jonathan Bain · Grand Cayman, Cayman IslandsDirector Justin Ryvicker · Whippany, NJExec · Director Ari Herman · New York, NYDirector Natan Linder · Boston, MADirector Udayan Umapathi · Boston, MADirector Connie Wang · Austin, TXExec · Director Rob Carlson · Frederick, MDDirector Daniella Kranjac · Frederick, MDDirector Jon Rowley · Frederick, MDExec Timothy Kelly · Frederick, MDDirector Robert Preti · Frederick, MDExec Eric Patterson · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗